Veradigm | MDRX - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Alcidion AUD 6.82M 1.16M 2025-12
Ambu A/S DKK 665M 40M 2026-06
Amplifon EUR 527.19M 77.51M 2026-06
Cardinal Health USD 61.23B 2.7B 2026-06
Centene USD 48.98B 4.59B 2026-06
Charles River Laboratories USD 655.29M 61.22M 2026-06
Cigna USD 65.13B 2.72B 2026-06
Coloplast 2.31B 110M 2025-12
Convatec Group USD 515.3M 270.15M 2024-12
CVS Health USD 90.35B 5.54B 2026-06
Diasorin EUR 101M 7.58M 2026-03
Elevance Health USD 38.07B 75M 2025-12
General Electric Aerospace USD 9.33B 439M 2026-09
Gulf Medical Proj AED 147.27M 3.78M 2026-03
Humana USD 26.54B 1.15B 2025-03
IQVIA Holdings USD 3.22B 141M 2026-06
Laboratory Of America USD 2.7B 97.8M 2026-06
Maximus USD 950.35M 33.65M 2026-06
McKesson USD 101.7B 9.44B 2026-06
Med Life RON 171.54M 112.24M 2026-03
Molina Healthcare USD 9.76B 277M 2026-09
Omnicell USD 159.27M 10.24M 2026-06
Oriola-kd EUR 11.4M 450.2M 2026-03
Owens Minor USD 436.92M 32.62M 2025-12
Quest Diagnostics USD 2.05B 64M 2026-06
Rede D'or Sao Luiz BRL 6.37B 4.76B 2026-06
Siemens Healthineers EUR 3.31B 226M 2026-06
Sonova Holding CHF 539.4M 11.5M 2025-12
UnitedHealth USD 88.73B 2.42B 2026-06
Veeva Systems USD 232.01M 11.09M 2026-06
Veradigm USD 124.74M 56.25M 2022-12
Xerox USD 1.14B 104M 2025-06